GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Daiken Medical Co Ltd (TSE:7775) » Definitions » ROCE %

Daiken Medical Co (TSE:7775) ROCE % : 25.58% (As of Dec. 2023)


View and export this data going back to 2009. Start your Free Trial

What is Daiken Medical Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Daiken Medical Co's annualized ROCE % for the quarter that ended in Dec. 2023 was 25.58%.


Daiken Medical Co ROCE % Historical Data

The historical data trend for Daiken Medical Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Daiken Medical Co ROCE % Chart

Daiken Medical Co Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.09 16.51 12.98 15.22 13.35

Daiken Medical Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.33 3.04 18.18 21.70 25.58

Daiken Medical Co ROCE % Calculation

Daiken Medical Co's annualized ROCE % for the fiscal year that ended in Mar. 2023 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2023 )  (A: Mar. 2022 )(A: Mar. 2023 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2023 )  (A: Mar. 2022 )(A: Mar. 2023 )
=1028.99/( ( (10920.803 - 3151.237) + (11013.404 - 3369.464) )/ 2 )
=1028.99/( (7769.566+7643.94)/ 2 )
=1028.99/7706.753
=13.35 %

Daiken Medical Co's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2023 )  (Q: Sep. 2023 )(Q: Dec. 2023 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2023 )  (Q: Sep. 2023 )(Q: Dec. 2023 )
=1955.592/( ( (11248.693 - 3607.181) + (11175.199 - 3525.418) )/ 2 )
=1955.592/( ( 7641.512 + 7649.781 )/ 2 )
=1955.592/7645.6465
=25.58 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Daiken Medical Co  (TSE:7775) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


Daiken Medical Co ROCE % Related Terms

Thank you for viewing the detailed overview of Daiken Medical Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Daiken Medical Co (TSE:7775) Business Description

Traded in Other Exchanges
N/A
Address
3-6-1, Dosho-Machi, Chuo-Ku, Osaka, JPN, 541-0045
Daiken Medical Co Ltd manufactures and sells medical equipment. The product line includes - Coopdech syrinjector, Coopdech Syrinjector PCA device, Coopdech Balloonjector, Coopdech Endobronchial blocker tube, Coopdech double-lumen endobronchial tube, Fit fix suction container system, Wet disinfectant mat, and others.

Daiken Medical Co (TSE:7775) Headlines

No Headlines